Real-time enrollment status for this eosinophilic granulomatosis with polyangiitis clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT05263934 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Eosinophilic Granulomatosis With Polyangiitis |
| Phase | Clinical Trial |
| Target Enrollment | 160 participants |
| Active Locations | 11 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | November 20, 2025 (Nov 20, 2025) |
As of March 2, 2026: Clinical trial NCT05263934 is currently active_not_recruiting participants. This clinical trial study for eosinophilic granulomatosis with polyangiitis is not currently accepting new participants at 11 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05263934 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05263934 was last updated Nov 20, 2025 (November 20, 2025). HelloStudys verifies this status automatically.